2021 Q3 Form 10-Q Financial Statement
#000163297021000113 Filed on November 15, 2021
Income Statement
Concept | 2021 Q3 | 2020 Q3 |
---|---|---|
Revenue | $37.21M | $18.95M |
YoY Change | 96.38% | -39.11% |
Cost Of Revenue | $14.54M | $17.40M |
YoY Change | -16.42% | 252.95% |
Gross Profit | $22.67M | $1.551M |
YoY Change | 1361.64% | -94.08% |
Gross Profit Margin | 60.92% | 8.19% |
Selling, General & Admin | ||
YoY Change | ||
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $8.181M | $7.966M |
YoY Change | 2.7% | 17.04% |
% of Gross Profit | 36.09% | 513.6% |
Operating Expenses | ||
YoY Change | ||
Operating Profit | $52.48M | |
YoY Change | ||
Interest Expense | $4.961M | $4.839M |
YoY Change | 2.52% | 16.88% |
% of Operating Profit | 9.45% | |
Other Income/Expense, Net | -$3.329M | -$6.822M |
YoY Change | -51.2% | -248.05% |
Pretax Income | -$5.898M | -$5.191M |
YoY Change | 13.62% | 171.64% |
Income Tax | $0.00 | -$39.00K |
% Of Pretax Income | ||
Net Earnings | -$5.777M | -$4.920M |
YoY Change | 17.42% | 159.08% |
Net Earnings / Revenue | -15.53% | -25.97% |
Basic Earnings Per Share | -$0.03 | |
Diluted Earnings Per Share | -$0.03 | |
COMMON SHARES | ||
Basic Shares Outstanding | 179.6M shares | |
Diluted Shares Outstanding | 179.6M shares |
Balance Sheet
Concept | 2021 Q3 | 2020 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | ||
YoY Change | ||
Cash & Equivalents | $16.18M | $22.69M |
Short-Term Investments | ||
Other Short-Term Assets | ||
YoY Change | ||
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | ||
YoY Change | ||
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | $54.75M | $68.64M |
YoY Change | -20.23% | -6.52% |
Long-Term Investments | $45.63M | $47.97M |
YoY Change | -4.88% | 1.42% |
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | ||
YoY Change | ||
TOTAL ASSETS | ||
Total Short-Term Assets | ||
Total Long-Term Assets | ||
Total Assets | $1.064B | $1.111B |
YoY Change | -4.28% | 7.12% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | ||
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | ||
YoY Change | ||
LONG-TERM LIABILITIES | ||
Long-Term Debt | ||
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | ||
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | ||
Total Long-Term Liabilities | ||
Total Liabilities | $546.0M | $549.6M |
YoY Change | -0.66% | 25.13% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$222.8M | -$172.4M |
YoY Change | 29.19% | 43.88% |
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $514.8M | $558.3M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $1.064B | $1.111B |
YoY Change | -4.28% | 7.12% |
Cashflow Statement
Concept | 2021 Q3 | 2020 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$5.777M | -$4.920M |
YoY Change | 17.42% | 159.08% |
Depreciation, Depletion And Amortization | $8.181M | $7.966M |
YoY Change | 2.7% | 17.04% |
Cash From Operating Activities | ||
YoY Change | ||
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | ||
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | ||
Cash From Investing Activities | ||
Cash From Financing Activities | ||
Net Change In Cash | ||
YoY Change | ||
FREE CASH FLOW | ||
Cash From Operating Activities | ||
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001632970 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
000-55775 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
AMERICAN HEALTHCARE REIT, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
MD | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
47-2887436 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
18191 Von Karman Avenue | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 300 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Irvine | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
92612 | ||
dei |
City Area Code
CityAreaCode
|
949 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
270-9200 | ||
dei |
Entity Information Former Legal Or Registered Name
EntityInformationFormerLegalOrRegisteredName
|
Griffin-American Healthcare REIT IV, Inc. | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
false | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
true | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2021Q3 | us-gaap |
Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
|
907103000 | USD |
CY2020Q4 | us-gaap |
Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
|
921580000 | USD |
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
16183000 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
17411000 | USD |
CY2021Q3 | us-gaap |
Restricted Cash
RestrictedCash
|
986000 | USD |
CY2020Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
714000 | USD |
CY2021Q3 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
2086000 | USD |
CY2020Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
2635000 | USD |
CY2021Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
54752000 | USD |
CY2020Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
64101000 | USD |
CY2021Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
14043000 | USD |
CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
14133000 | USD |
CY2021Q3 | us-gaap |
Other Assets
OtherAssets
|
68743000 | USD |
CY2020Q4 | us-gaap |
Other Assets
OtherAssets
|
72199000 | USD |
CY2021Q3 | us-gaap |
Assets
Assets
|
1063896000 | USD |
CY2020Q4 | us-gaap |
Assets
Assets
|
1092773000 | USD |
CY2021Q3 | us-gaap |
Secured Debt
SecuredDebt
|
17409000 | USD |
CY2020Q4 | us-gaap |
Secured Debt
SecuredDebt
|
17827000 | USD |
CY2021Q3 | us-gaap |
Line Of Credit
LineOfCredit
|
488900000 | USD |
CY2020Q4 | us-gaap |
Line Of Credit
LineOfCredit
|
476900000 | USD |
CY2021Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
21897000 | USD |
CY2020Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
23057000 | USD |
CY2021Q3 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
324000 | USD |
CY2020Q4 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
1046000 | USD |
CY2021Q3 | us-gaap |
Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
|
1115000 | USD |
CY2020Q4 | us-gaap |
Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
|
1295000 | USD |
CY2021Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
10021000 | USD |
CY2020Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
9904000 | USD |
CY2021Q3 | us-gaap |
Other Liabilities
OtherLiabilities
|
6300000 | USD |
CY2020Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
10387000 | USD |
CY2021Q3 | us-gaap |
Liabilities
Liabilities
|
545966000 | USD |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
540416000 | USD |
CY2021Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2021Q3 | us-gaap |
Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
|
2592000 | USD |
CY2020Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
|
2618000 | USD |
CY2021Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
200000000 | shares |
CY2021Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
200000000 | shares |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2021Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
736756000 | USD |
CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
733192000 | USD |
CY2021Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-222775000 | USD |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-185047000 | USD |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
514798000 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
548958000 | USD |
CY2021Q3 | us-gaap |
Minority Interest
MinorityInterest
|
540000 | USD |
CY2020Q4 | us-gaap |
Minority Interest
MinorityInterest
|
781000 | USD |
CY2021Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
515338000 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
549739000 | USD |
CY2021Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1063896000 | USD |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1092773000 | USD |
CY2021Q3 | us-gaap |
Line Of Credit
LineOfCredit
|
488900000 | USD |
CY2020Q4 | us-gaap |
Line Of Credit
LineOfCredit
|
476900000 | USD |
CY2021Q3 | us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
22120000 | USD |
CY2020Q3 | us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
21519000 | USD |
us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
66054000 | USD | |
us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
64824000 | USD | |
CY2021Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
15090000 | USD |
CY2020Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
18948000 | USD |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
46179000 | USD | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
51863000 | USD | |
CY2021Q3 | ahr |
Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
|
0 | USD |
CY2020Q3 | ahr |
Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
|
864000 | USD |
ahr |
Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
|
0 | USD | |
ahr |
Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
|
864000 | USD | |
CY2021Q3 | ahr |
Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
|
37210000 | USD |
CY2020Q3 | ahr |
Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
|
41331000 | USD |
ahr |
Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
|
112233000 | USD | |
ahr |
Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
|
117551000 | USD | |
CY2021Q3 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
6389000 | USD |
CY2020Q3 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
5905000 | USD |
us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
18542000 | USD | |
us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
17723000 | USD | |
CY2021Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
14540000 | USD |
CY2020Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
17397000 | USD |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
44179000 | USD | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
44856000 | USD | |
CY2021Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4304000 | USD |
CY2020Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3672000 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11710000 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11960000 | USD | |
CY2021Q3 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
3800000 | USD |
CY2020Q3 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
57000 | USD |
us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
6552000 | USD | |
us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
74000 | USD | |
CY2021Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
10746000 | USD |
CY2020Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
12669000 | USD |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
33745000 | USD | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
37919000 | USD | |
CY2021Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
39779000 | USD |
CY2020Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
39700000 | USD |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
114728000 | USD | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
112532000 | USD | |
CY2021Q3 | us-gaap |
Interest Expense
InterestExpense
|
4961000 | USD |
CY2020Q3 | us-gaap |
Interest Expense
InterestExpense
|
4839000 | USD |
us-gaap |
Interest Expense
InterestExpense
|
14556000 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
15123000 | USD | |
CY2021Q3 | us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
1514000 | USD |
CY2020Q3 | us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
1450000 | USD |
us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
4431000 | USD | |
us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
-2302000 | USD | |
CY2021Q3 | us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
0 | USD |
CY2020Q3 | us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
3064000 | USD |
us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
0 | USD | |
us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
3064000 | USD | |
CY2021Q3 | us-gaap |
Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
|
15000 | USD |
CY2020Q3 | us-gaap |
Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
|
0 | USD |
us-gaap |
Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
|
-184000 | USD | |
us-gaap |
Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
|
0 | USD | |
CY2021Q3 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
70000 | USD |
CY2020Q3 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-377000 | USD |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-1027000 | USD | |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
952000 | USD | |
CY2021Q3 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
33000 | USD |
CY2020Q3 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
8000 | USD |
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
49000 | USD | |
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
278000 | USD | |
CY2021Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-3329000 | USD |
CY2020Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-6822000 | USD |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-11287000 | USD | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-19259000 | USD | |
CY2021Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-5898000 | USD |
CY2020Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-5191000 | USD |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-13782000 | USD | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-14240000 | USD | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-14240000 | USD | |
CY2021Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2020Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-39000 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD | |
CY2021Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-5898000 | USD |
CY2020Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-5152000 | USD |
us-gaap |
Profit Loss
ProfitLoss
|
-13782000 | USD | |
us-gaap |
Profit Loss
ProfitLoss
|
-14240000 | USD | |
us-gaap |
Profit Loss
ProfitLoss
|
-14240000 | USD | |
CY2021Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-121000 | USD |
CY2020Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-232000 | USD |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-489000 | USD | |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-608000 | USD | |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5777000 | USD |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4920000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-13293000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-13632000 | USD | |
CY2021Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.07 | |
CY2020Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.06 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.16 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.17 | ||
CY2020Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
44000 | USD |
CY2021Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
81704261 | shares |
CY2020Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
80788359 | shares |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
81635053 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
80498693 | shares | |
CY2021Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
529462000 | USD |
CY2021Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
21000 | USD |
CY2021Q3 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
7000 | USD |
CY2021Q3 | ahr |
Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
|
92000 | USD |
CY2021Q3 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.10 | |
CY2021Q3 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
8239000 | USD |
CY2021Q3 | ahr |
Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
|
-5807000 | USD |
CY2021Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
515338000 | USD |
CY2020Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
569002000 | USD |
CY2020Q3 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
5000 | USD |
CY2020Q3 | us-gaap |
Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
|
4247000 | USD |
CY2020Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
29000 | USD |
ahr |
Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
|
-13472000 | USD | |
CY2020Q3 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
706000 | USD |
CY2020Q3 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
22000 | USD |
CY2020Q3 | ahr |
Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
|
208000 | USD |
CY2020Q3 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.10 | |
CY2020Q3 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
8150000 | USD |
CY2020Q3 | ahr |
Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
|
-5025000 | USD |
CY2020Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
559216000 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
549739000 | USD |
us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
5000 | USD | |
us-gaap |
Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
|
5499000 | USD | |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
105000 | USD | |
us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
1874000 | USD | |
us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
62000 | USD | |
ahr |
Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
|
167000 | USD | |
us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.30 | ||
us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
24435000 | USD | |
CY2021Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
515338000 | USD |
CY2019Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
590079000 | USD |
ahr |
Adjustments To Additional Paid In Capital Stock Issued Offering Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedOfferingCosts
|
-67000 | USD | |
us-gaap |
Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
|
15681000 | USD | |
us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
43000 | USD | |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
128000 | USD | |
us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
5349000 | USD | |
us-gaap |
Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
|
1250000 | USD | |
us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
54000 | USD | |
ahr |
Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
|
530000 | USD | |
us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.35 | ||
us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
28191000 | USD | |
ahr |
Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
|
-13908000 | USD | |
CY2020Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
559216000 | USD |
CY2021Q3 | us-gaap |
Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
|
-91000 | USD |
CY2020Q3 | us-gaap |
Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
|
-127000 | USD |
us-gaap |
Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
|
-310000 | USD | |
us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
0 | USD | |
us-gaap |
Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
|
-332000 | USD | |
us-gaap |
Profit Loss
ProfitLoss
|
-13782000 | USD | |
us-gaap |
Profit Loss
ProfitLoss
|
-14240000 | USD | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
33745000 | USD | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
37919000 | USD | |
ahr |
Other Amortization
OtherAmortization
|
2099000 | USD | |
ahr |
Other Amortization
OtherAmortization
|
2084000 | USD | |
us-gaap |
Straight Line Rent Adjustments
StraightLineRentAdjustments
|
-2707000 | USD | |
us-gaap |
Straight Line Rent Adjustments
StraightLineRentAdjustments
|
-3440000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
105000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
171000 | USD | |
us-gaap |
Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
|
-184000 | USD | |
us-gaap |
Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
|
0 | USD | |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-1027000 | USD | |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
952000 | USD | |
us-gaap |
Increase Decrease In Other Financial Instruments Used In Operating Activities
IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities
|
4431000 | USD | |
us-gaap |
Increase Decrease In Other Financial Instruments Used In Operating Activities
IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities
|
-2302000 | USD | |
us-gaap |
Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
|
6196000 | USD | |
us-gaap |
Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
|
0 | USD | |
us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
3064000 | USD | |
us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
-533000 | USD | |
us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
-1347000 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2829000 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1654000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
3805000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
3436000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
-921000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
27000 | USD | |
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
309000 | USD | |
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
306000 | USD | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
37000 | USD | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
185000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
16556000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
29943000 | USD | |
us-gaap |
Payments To Acquire And Develop Real Estate
PaymentsToAcquireAndDevelopRealEstate
|
3385000 | USD | |
us-gaap |
Payments To Acquire And Develop Real Estate
PaymentsToAcquireAndDevelopRealEstate
|
68032000 | USD | |
us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
4384000 | USD | |
us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
6729000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1573000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-74761000 | USD | |
us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
475000 | USD | |
us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
8166000 | USD | |
us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
17000000 | USD | |
us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
140800000 | USD | |
us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
5000000 | USD | |
us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
58100000 | USD | |
us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
0 | USD | |
us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
43000 | USD | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
3940000 | USD | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
4876000 | USD | |
us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
21700000 | USD | |
us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
13932000 | USD | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
1874000 | USD | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
5349000 | USD | |
us-gaap |
Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
|
0 | USD | |
us-gaap |
Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
|
1250000 | USD | |
us-gaap |
Payments To Minority Shareholders
PaymentsToMinorityShareholders
|
62000 | USD | |
us-gaap |
Payments To Minority Shareholders
PaymentsToMinorityShareholders
|
54000 | USD | |
ahr |
Proceedsfrom Redeemable Noncontrolling Interests
ProceedsfromRedeemableNoncontrollingInterests
|
125000 | USD | |
ahr |
Proceedsfrom Redeemable Noncontrolling Interests
ProceedsfromRedeemableNoncontrollingInterests
|
1118000 | USD | |
ahr |
Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
|
8000 | USD | |
ahr |
Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
|
81000 | USD | |
ahr |
Payments For Proceeds From Security Deposits Financing Activities
PaymentsForProceedsFromSecurityDepositsFinancingActivities
|
-5000 | USD | |
ahr |
Payments For Proceeds From Security Deposits Financing Activities
PaymentsForProceedsFromSecurityDepositsFinancingActivities
|
-199000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-15939000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
52368000 | USD | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-956000 | USD | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
7550000 | USD | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
18125000 | USD |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
15846000 | USD |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
17169000 | USD |
CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
23396000 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
17411000 | USD |
CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
15290000 | USD |
CY2020Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
714000 | USD |
CY2019Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
556000 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
18125000 | USD |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
15846000 | USD |
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
16183000 | USD |
CY2020Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
22690000 | USD |
CY2021Q3 | us-gaap |
Restricted Cash
RestrictedCash
|
986000 | USD |
CY2020Q3 | us-gaap |
Restricted Cash
RestrictedCash
|
706000 | USD |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
17169000 | USD |
CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
23396000 | USD |
us-gaap |
Interest Paid Net
InterestPaidNet
|
13116000 | USD | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
13777000 | USD | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
51000 | USD | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
88000 | USD | |
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
3720000 | USD | |
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
2182000 | USD | |
ahr |
Tenant Improvement Overage
TenantImprovementOverage
|
303000 | USD | |
ahr |
Tenant Improvement Overage
TenantImprovementOverage
|
636000 | USD | |
ahr |
Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Other Assets
NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInOtherAssets
|
-16000 | USD | |
ahr |
Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Other Assets
NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInOtherAssets
|
196000 | USD | |
ahr |
Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Accounts Payable And Accrued Expenses
NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInAccountsPayableAndAccruedExpenses
|
-50000 | USD | |
ahr |
Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Accounts Payable And Accrued Expenses
NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInAccountsPayableAndAccruedExpenses
|
201000 | USD | |
us-gaap |
Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
|
10000 | USD | |
us-gaap |
Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
|
11000 | USD | |
us-gaap |
Stock Issued1
StockIssued1
|
5499000 | USD | |
us-gaap |
Stock Issued1
StockIssued1
|
15681000 | USD | |
CY2021Q3 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
0 | USD |
CY2020Q3 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
2664000 | USD |
CY2021Q3 | ahr |
Accruedstockholderservicingfee
Accruedstockholderservicingfee
|
2157000 | USD |
CY2020Q3 | ahr |
Accruedstockholderservicingfee
Accruedstockholderservicingfee
|
7667000 | USD |
us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Organization and Description of Business </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Healthcare REIT, Inc. (formerly known as Griffin-American Healthcare REIT IV, Inc.), a Maryland corporation, invests in a diversified portfolio of healthcare real estate properties, focusing primarily on medical office buildings, skilled nursing facilities and senior housing facilities that produce current income. We also operate healthcare-related facilities utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a “RIDEA” structure (the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted as part of the Housing and Economic Recovery Act of 2008). We qualified to be taxed as a real estate investment trust, or REIT, under the Code for federal income tax purposes beginning with our taxable year ended December 31, 2016, and we intend to continue to qualify to be taxed as a REIT.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We raised $754,118,000 through a best efforts initial public offering, or our initial offering, that commenced on February 16, 2016, and issued 75,639,681 aggregate shares of our Class T and Class I common stock. In addition, during our initial offering, we issued 3,253,535 aggregate shares of our Class T and Class I common stock pursuant to our distribution reinvestment plan, as amended, or the DRIP, for a total of $31,021,000 in distributions reinvested. Following the termination of our initial offering on February 15, 2019, we continued issuing shares of our common stock pursuant to the DRIP through a subsequent offering, or the 2019 DRIP Offering, which commenced on March 1, 2019. On March 18, 2021, our board of directors, or our board, authorized the suspension of the DRIP, effective as of April 1, 2021. As of September 30, 2021, a total of $46,970,000 in distributions were reinvested that resulted in 4,923,550 shares of our common stock being issued pursuant to the 2019 DRIP Offering. We collectively refer to the DRIP portion of our initial offering and the 2019 DRIP Offering as our DRIP Offerings. See Note 12, Equity — Distribution Reinvestment Plan, for a further discussion. On October 4, 2021, our board authorized the reinstatement of the DRIP. See Note 20, Subsequent Events —</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinstatement of the DRIP, for a further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until October 1, 2021, we conducted substantially all of our operations through Griffin-American Healthcare REIT IV Holdings, LP, or our operating partnership. Through September 30, 2021, we were externally advised by Griffin-American Healthcare REIT IV Advisor, LLC, or our advisor, pursuant to an advisory agreement, as amended, or the Advisory Agreement, between us, our operating partnership and our advisor. The Advisory Agreement was effective as of February 16, 2016 and had a one-year initial term, subject to successive one-year renewals upon the mutual consent of the parties. The Advisory Agreement was last renewed pursuant to the mutual consent of the parties on February 11, 2021. On June 23, 2021, in anticipation of the Merger, as defined and discussed below, we entered into an amendment to the Advisory Agreement, whereby it was agreed that any acquisition fee due to our advisor is to be waived in connection with the REIT Merger, as defined and discussed below. Except as set forth in such amendment to the Advisory Agreement, the terms of the Advisory Agreement continued in full force and effect. Our advisor used its best efforts, subject to the oversight and review of our board, to, among other things, provide asset management, property management, acquisition, disposition and other advisory services on our behalf consistent with our investment policies and objectives. Our advisor performed its duties and responsibilities under the Advisory Agreement as our fiduciary. Prior to the Merger, our advisor was 75.0% owned and managed by wholly owned subsidiaries of American Healthcare Investors, LLC, or American Healthcare Investors, and 25.0% owned by a wholly owned subsidiary of Griffin Capital Company, LLC, or Griffin Capital, or collectively, our co-sponsors. American Healthcare Investors was 47.1% owned by AHI Group Holdings, LLC, or AHI Group Holdings, 45.1% indirectly owned by Digital Bridge Group, Inc. (NYSE: DBRG) (formerly known as Colony Capital, Inc.), or Digital Bridge, and 7.8% owned by James F. Flaherty III, a former partner of Colony Capital, Inc. We were not affiliated with Griffin Capital, Griffin Capital Securities, LLC, or our dealer manager, Digital Bridge or Mr. Flaherty; however, we were affiliated with our advisor, American Healthcare Investors and AHI Group Holdings. Please see the “Merger with Griffin-American Healthcare REIT III, Inc.” and “AHI Acquisition” sections below for a further discussion of our operations effective October 1, 2021.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We operate through four reportable business segments: medical office buildings, senior housing, senior housing — RIDEA and skilled nursing facilities. As of September 30, 2021, we owned 87 properties, comprising 92 buildings, or approximately 4,799,000 square feet of gross leasable area, or GLA, for an aggregate contract purchase price of $1,080,381,000. As of September 30, 2021, we also owned a 6.0% interest in a joint venture which owned a portfolio of integrated senior health campuses and ancillary businesses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Due to the ongoing coronavirus, or COVID-19, pandemic in the United States and globally, since March 2020, our residents, tenants, operating partners and managers have been materially impacted, and the prolonged economic impact remains </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">uncertain. As the COVID-19 pandemic is still impacting the healthcare system to a degree, it continues to present challenges for us as an owner and operator of healthcare facilities. Since its outset, the impacts of the COVID-19 pandemic have been significant, rapidly and continuously evolving and may continue into the future, especially due to the emergence of the Delta variant which has caused COVID-19 cases and deaths to increase significantly in recent months, making it difficult to ascertain the long-term impact the COVID-19 pandemic will have on real estate markets in which we own and/or operate properties and our portfolio of investments. We have evaluated the impacts of the COVID-19 pandemic on our business thus far and incorporated information concerning the impact of COVID-19 into our assessments of liquidity, impairment and collectability from tenants and residents as of September 30, 2021. We will continue to monitor such impacts and will adjust our estimates and assumptions based on the best available information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Merger with Griffin-American Healthcare REIT III, Inc. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 23, 2021, we, our operating partnership, our wholly owned subsidiary, Continental Merger Sub, LLC, or merger sub, Griffin-American Healthcare REIT III, Inc., or GAHR III, and American Healthcare REIT Holdings, LP (formerly known as Griffin-American Healthcare REIT III Holdings, LP), or the surviving partnership, entered into an Agreement and Plan of Merger, or the Merger Agreement. On October 1, 2021, pursuant to the Merger Agreement, (i) GAHR III merged with and into merger sub, with merger sub being the surviving company, or the REIT Merger, and (ii) our operating partnership merged with and into the surviving partnership, with the surviving partnership being the surviving entity and being renamed American Healthcare REIT Holdings, LP, or the Partnership Merger, and, together with the REIT Merger, the Merger. As a result of and at the effective time of the Merger, the separate corporate existence of GAHR III and our operating partnership ceased. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following the Merger, our company, combined with GAHR III, or the Combined Company, was renamed “American Healthcare REIT, Inc.” The REIT Merger is intended to qualify as a “reorganization” under, and within the meaning of, Section 368(a) of the Code.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:109%">AHI Acquisition</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Also on June 23, 2021, the surviving partnership, our co-sponsors, Platform Healthcare Investor T-II, LLC, Flaherty Trust, Jeffrey T. Hanson, our former Chief Executive Officer and Chairman of the Board of Directors, Danny Prosky, our President and former Chief Operating Officer, and Mathieu B. Streiff, our former Executive Vice President, General Counsel, entered into a contribution and exchange agreement, or the Contribution Agreement, pursuant to which, among other things, the surviving partnership agreed to acquire a newly formed entity, or NewCo, which we refer to as the AHI Acquisition, that owned substantially all of the business and operations of one of our co-sponsors, American Healthcare Investors, as well as all of the equity interests in (i) Griffin-American Healthcare REIT III Advisor, LLC, or GAHR III Advisor, a subsidiary of American Healthcare Investors that served as the external advisor of GAHR III, and (ii) our advisor. On October 1, 2021, the AHI Acquisition closed immediately prior to the consummation of the Merger. Following the consummation of the Merger, the Combined Company has become a self-managed company. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The AHI Acquisition will be treated as a business combination for accounting purposes, with GAHR III as both the legal and accounting acquiror of NewCo. While we are the legal acquiror of GAHR III in the REIT Merger, GAHR III was determined to be the accounting acquiror in the REIT Merger transaction in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, after considering the relative share ownership and the composition of the governing body of the Combined Company. As a result of the completion of the Merger and the AHI Acquisition, the historical information regarding our company’s structure, agreements and financial information presented within this Note 1 and throughout the rest of the Notes to Condensed Consolidated Financial Statements has materially changed; however, such information did apply to us as of September 30, 2021. See Note 20, Subsequent Events — Merger with Griffin-American Healthcare REIT III, Inc. and AHI Acquisition, for a further discussion about the Merger and the AHI Acquisition.</span></div> | ||
us-gaap |
Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
|
3253535 | shares | |
us-gaap |
Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
|
31021000 | USD | |
CY2017 | ahr |
Advisory Agreement Term
AdvisoryAgreementTerm
|
P1Y | |
CY2017 | ahr |
Advisory Agreement Term
AdvisoryAgreementTerm
|
P1Y | |
CY2021Q3 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
4 | segment |
ahr |
Numberof Properties Acquiredfrom Unaffiliated Parties
NumberofPropertiesAcquiredfromUnaffiliatedParties
|
87 | Property | |
ahr |
Number Of Buildings Acquired From Unaffiliated Parties
NumberOfBuildingsAcquiredFromUnaffiliatedParties
|
92 | Building | |
CY2021Q3 | us-gaap |
Area Of Real Estate Property
AreaOfRealEstateProperty
|
4799000 | sqft |
ahr |
Acquisition Aggregated Cost Of Acquired Properties Purchase Price
AcquisitionAggregatedCostOfAcquiredPropertiesPurchasePrice
|
1080381000 | USD | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date of our condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the initial and recurring valuation of certain assets acquired and liabilities assumed through property acquisitions, revenues and grant income, allowance for credit losses, impairment of long-lived and intangible assets and contingencies. These estimates are made and evaluated on an on-going basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.</span></div> | ||
us-gaap |
Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
|
<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tenant and Resident Receivables and Allowances</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resident receivables, which are related to resident fees and services, are carried net of an allowance for credit losses. An allowance is maintained for estimated losses resulting from the inability of residents and payors to meet the contractual obligations under their lease or service agreements. Substantially all of such allowances are recorded as direct reductions of resident fees and services revenue as contractual adjustments provided to third-party payors or implicit price concessions in our accompanying condensed consolidated statements of operations. Our determination of the adequacy of these allowances is based primarily upon evaluations of historical loss experience, the residents’ financial condition, security deposits, cash collection patterns by payor and by state, current economic conditions, future expectations in estimating credit losses and other relevant factors. Tenant receivables, which are related to real estate revenue, and unbilled deferred rent receivables are reduced for uncollectible amounts, which are recognized as direct reductions of real estate revenue in our accompanying condensed consolidated statements of operations.</span></div> | ||
CY2021Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
2219000 | USD |
CY2020Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
2086000 | USD |
us-gaap |
Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
|
839000 | USD | |
us-gaap |
Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
|
937000 | USD | |
ahr |
Financing Receivable Allowancefor Credit Loss Collectionsor Adjustments
FinancingReceivableAllowanceforCreditLossCollectionsorAdjustments
|
-350000 | USD | |
ahr |
Financing Receivable Allowancefor Credit Loss Collectionsor Adjustments
FinancingReceivableAllowanceforCreditLossCollectionsorAdjustments
|
-126000 | USD | |
us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
356000 | USD | |
us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
60000 | USD | |
CY2021Q3 | us-gaap |
Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
|
1011829000 | USD |
CY2020Q4 | us-gaap |
Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
|
1002859000 | USD |
CY2021Q3 | us-gaap |
Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
|
104726000 | USD |
CY2020Q4 | us-gaap |
Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
|
81279000 | USD |
CY2021Q3 | us-gaap |
Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
|
907103000 | USD |
CY2020Q4 | us-gaap |
Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
|
921580000 | USD |
CY2021Q3 | us-gaap |
Depreciation
Depreciation
|
8181000 | USD |
CY2020Q3 | us-gaap |
Depreciation
Depreciation
|
7966000 | USD |
us-gaap |
Depreciation
Depreciation
|
24025000 | USD | |
us-gaap |
Depreciation
Depreciation
|
23698000 | USD | |
ahr |
Capitalized Acquisition Costsand Fees Additions
CapitalizedAcquisitionCostsandFeesAdditions
|
94000 | USD | |
us-gaap |
Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
|
-184000 | USD | |
CY2021Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
54752000 | USD |
CY2020Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
64101000 | USD |
CY2021Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2358000 | USD |
CY2020Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
4728000 | USD |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
9495000 | USD | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
14361000 | USD | |
us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P8Y9M18D | ||
CY2020 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P8Y9M18D | |
CY2021Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
2396000 | USD |
CY2021Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
8647000 | USD |
CY2021Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
7390000 | USD |
CY2021Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
6195000 | USD |
CY2021Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
5017000 | USD |
CY2021Q3 | ahr |
Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
|
24759000 | USD |
CY2021Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
54404000 | USD |
CY2021Q3 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
45627000 | USD |
CY2020Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
46653000 | USD |
CY2021Q3 | us-gaap |
Deferred Rent Receivables Net
DeferredRentReceivablesNet
|
15101000 | USD |
CY2020Q4 | us-gaap |
Deferred Rent Receivables Net
DeferredRentReceivablesNet
|
12395000 | USD |
CY2021Q3 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
3939000 | USD |
CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
9028000 | USD |
CY2021Q3 | us-gaap |
Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
|
687000 | USD |
CY2020Q4 | us-gaap |
Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
|
426000 | USD |
CY2021Q3 | us-gaap |
Deferred Costs Leasing Net
DeferredCostsLeasingNet
|
3763000 | USD |
CY2020Q4 | us-gaap |
Deferred Costs Leasing Net
DeferredCostsLeasingNet
|
2399000 | USD |
CY2021Q3 | us-gaap |
Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
|
4808000 | USD |
CY2020Q4 | us-gaap |
Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
|
3397000 | USD |
CY2021Q3 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
313000 | USD |
CY2020Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
1724000 | USD |
CY2021Q3 | us-gaap |
Other Assets
OtherAssets
|
68743000 | USD |
CY2020Q4 | us-gaap |
Other Assets
OtherAssets
|
72199000 | USD |
CY2021Q3 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
470000 | USD |
CY2020Q3 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
471000 | USD |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
1411000 | USD | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
1410000 | USD | |
CY2021Q3 | ahr |
Joint Ventureunamortizedbasisdifference
JointVentureunamortizedbasisdifference
|
16448000 | USD |
CY2020Q4 | ahr |
Joint Ventureunamortizedbasisdifference
JointVentureunamortizedbasisdifference
|
16791000 | USD |
CY2021Q3 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
18291000 | USD |
CY2021Q3 | us-gaap |
Secured Debt
SecuredDebt
|
17409000 | USD |
CY2020Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
18766000 | USD |
CY2020Q4 | us-gaap |
Secured Debt
SecuredDebt
|
17827000 | USD |
CY2021Q3 | ahr |
Number Of Fixed Rate Mortgage Loans Payable
NumberOfFixedRateMortgageLoansPayable
|
3 | MortgageLoan |
CY2020Q4 | ahr |
Number Of Fixed Rate Mortgage Loans Payable
NumberOfFixedRateMortgageLoansPayable
|
3 | MortgageLoan |
CY2020Q1 | ahr |
Payoffofmortgageloanpayable
Payoffofmortgageloanpayable
|
7738000 | USD |
CY2020Q4 | us-gaap |
Secured Debt
SecuredDebt
|
17827000 | USD |
CY2019Q4 | us-gaap |
Secured Debt
SecuredDebt
|
26070000 | USD |
ahr |
Amortizationofdeferredfinancingcostsrelatedtomortgage
Amortizationofdeferredfinancingcostsrelatedtomortgage
|
20000 | USD | |
ahr |
Amortizationofdeferredfinancingcostsrelatedtomortgage
Amortizationofdeferredfinancingcostsrelatedtomortgage
|
33000 | USD | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
-37000 | USD | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
-37000 | USD | |
us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
475000 | USD | |
us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
8166000 | USD | |
CY2021Q3 | us-gaap |
Secured Debt
SecuredDebt
|
17409000 | USD |
CY2020Q3 | us-gaap |
Secured Debt
SecuredDebt
|
17974000 | USD |
CY2021Q3 | us-gaap |
Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
|
132000 | USD |
CY2021Q3 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
651000 | USD |
CY2021Q3 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
680000 | USD |
CY2021Q3 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
711000 | USD |
CY2021Q3 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
5878000 | USD |
CY2021Q3 | ahr |
Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
|
10239000 | USD |
CY2021Q3 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
18291000 | USD |
CY2018Q4 | ahr |
Line Of Credit Facility Number Of Potential Extensions
LineOfCreditFacilityNumberOfPotentialExtensions
|
1 | Extension |
CY2018Q4 | ahr |
Line Of Credit Facility Potential Extension Term
LineOfCreditFacilityPotentialExtensionTerm
|
P12M | |
CY2020Q4 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
530000000 | USD |
CY2021Q3 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
530000000 | USD |
CY2021Q3 | us-gaap |
Line Of Credit
LineOfCredit
|
488900000 | USD |
CY2020Q4 | us-gaap |
Line Of Credit
LineOfCredit
|
476900000 | USD |
CY2021Q3 | us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
1514000 | USD |
CY2020Q3 | us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
1450000 | USD |
us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
4431000 | USD | |
us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
-2302000 | USD | |
CY2021Q3 | ahr |
Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
|
59000 | USD |
CY2020Q3 | ahr |
Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
|
78000 | USD |
ahr |
Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
|
181000 | USD | |
ahr |
Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
|
239000 | USD | |
ahr |
Finite Lived Intangible Liabilities Useful Life
FiniteLivedIntangibleLiabilitiesUsefulLife
|
P12Y | ||
CY2020 | ahr |
Finite Lived Intangible Liabilities Useful Life
FiniteLivedIntangibleLiabilitiesUsefulLife
|
P11Y7M6D | |
CY2021Q3 | ahr |
Finite Lived Intangible Liabilities Amortization Expenses Remainder Of Fiscal Year
FiniteLivedIntangibleLiabilitiesAmortizationExpensesRemainderOfFiscalYear
|
55000 | USD |
CY2021Q3 | ahr |
Finite Lived Intangible Liabilities Amortization Expenses Year Two
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearTwo
|
217000 | USD |
CY2021Q3 | ahr |
Finite Lived Intangible Liabilities Amortization Expenses Year Three
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearThree
|
207000 | USD |
CY2021Q3 | ahr |
Finite Lived Intangible Liabilities Amortization Expenses Year Four
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFour
|
161000 | USD |
CY2021Q3 | ahr |
Finite Lived Intangible Liabilities Amortization Expenses Year Five
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFive
|
123000 | USD |
CY2021Q3 | ahr |
Finite Lived Intangible Liabilities Amortization Expenses After Year Five
FiniteLivedIntangibleLiabilitiesAmortizationExpensesAfterYearFive
|
352000 | USD |
CY2021Q3 | ahr |
Finite Lived Intangible Liabilities Net
FiniteLivedIntangibleLiabilitiesNet
|
1115000 | USD |
CY2020Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
|
2618000 | USD |
CY2019Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
|
1462000 | USD |
ahr |
Proceedsfromredeemablenoncontrollinginterest
Proceedsfromredeemablenoncontrollinginterest
|
125000 | USD | |
ahr |
Proceedsfromredeemablenoncontrollinginterest
Proceedsfromredeemablenoncontrollinginterest
|
1118000 | USD | |
ahr |
Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
|
8000 | USD | |
ahr |
Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
|
81000 | USD | |
ahr |
Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
|
167000 | USD | |
ahr |
Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
|
530000 | USD | |
us-gaap |
Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
|
-310000 | USD | |
us-gaap |
Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
|
-332000 | USD | |
CY2021Q3 | us-gaap |
Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
|
2592000 | USD |
CY2020Q3 | us-gaap |
Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
|
2697000 | USD |
CY2021Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
200000000 | shares |
CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
200000000 | shares |
CY2021Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2021Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
us-gaap |
Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
|
8177085 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
105000 | shares | |
ahr |
Common Stock Repurchased During Period Under Share Repurchase Plan Shares
CommonStockRepurchasedDuringPeriodUnderShareRepurchasePlanShares
|
2211338 | shares | |
CY2021Q3 | us-gaap |
Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
|
0 | USD |
CY2020Q3 | us-gaap |
Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
|
4247000 | USD |
us-gaap |
Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
|
5499000 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan
ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
|
77991000 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan
ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
|
72492000 | USD | |
us-gaap |
Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
|
8177085 | shares | |
us-gaap |
Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
|
7595594 | shares | |
ahr |
Maximum Percentage Of Common Stock Repurchased During Period
MaximumPercentageOfCommonStockRepurchasedDuringPeriod
|
0.050 | ||
CY2021Q3 | ahr |
Share Repurchase Plan Percentageof Priceper Share Condition Two
ShareRepurchasePlanPercentageofPriceperShareConditionTwo
|
1 | |
CY2020Q3 | ahr |
Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
|
9.87 | |
ahr |
Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
|
9.88 | ||
ahr |
Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
|
9.25 | ||
us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
2211338 | shares | |
us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
2021771 | shares | |
ahr |
Stock Repuchased During Period Value Under Share Repurchase Plan Value
StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue
|
20744000 | USD | |
ahr |
Stock Repuchased During Period Value Under Share Repurchase Plan Value
StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue
|
18870000 | USD | |
ahr |
Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
|
9.38 | ||
ahr |
Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
|
9.33 | ||
CY2021Q3 | us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
3129000 | USD |
CY2020Q3 | us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
3045000 | USD |
us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
9574000 | USD | |
us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
10344000 | USD | |
CY2021Q3 | us-gaap |
Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
|
324000 | USD |
CY2020Q4 | us-gaap |
Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
|
1046000 | USD |
CY2021Q3 | us-gaap |
Secured Debt
SecuredDebt
|
17409000 | USD |
CY2021Q3 | us-gaap |
Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
|
20891000 | USD |
CY2020Q4 | us-gaap |
Secured Debt
SecuredDebt
|
17827000 | USD |
CY2020Q4 | us-gaap |
Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
|
22052000 | USD |
CY2021Q3 | ahr |
Linesofcreditandtermloannet
Linesofcreditandtermloannet
|
488587000 | USD |
CY2021Q3 | us-gaap |
Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
|
488995000 | USD |
CY2020Q4 | ahr |
Linesofcreditandtermloannet
Linesofcreditandtermloannet
|
475176000 | USD |
CY2020Q4 | us-gaap |
Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
|
477651000 | USD |
CY2021Q3 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
914000 | USD |
CY2020Q3 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
863000 | USD |
us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
2717000 | USD | |
us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
2134000 | USD | |
us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
791000 | USD | |
CY2021Q3 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
232000 | USD |
CY2020Q3 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
327000 | USD |
us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
721000 | USD | |
CY2021Q3 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
CY2020Q3 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
-37000 | USD |
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD | |
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD | |
CY2021Q3 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
CY2020Q3 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
-2000 | USD |
us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD | |
us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD | |
CY2021Q3 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1146000 | USD |
CY2020Q3 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1190000 | USD |
us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
3508000 | USD | |
us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
2855000 | USD | |
CY2021Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2020Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-39000 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD | |
CY2021Q3 | us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
22120000 | USD |
CY2020Q3 | us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
21519000 | USD |
CY2021Q3 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
5013000 | USD |
CY2020Q3 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
4592000 | USD |
us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
66054000 | USD | |
us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
64824000 | USD | |
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
14817000 | USD | |
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
13861000 | USD | |
CY2021Q3 | us-gaap |
Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
|
16361000 | USD |
CY2021Q3 | us-gaap |
Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
|
64121000 | USD |
CY2021Q3 | us-gaap |
Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
|
60213000 | USD |
CY2021Q3 | us-gaap |
Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
|
49138000 | USD |
CY2021Q3 | ahr |
Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
|
283142000 | USD |
CY2021Q3 | us-gaap |
Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
|
54662000 | USD |
CY2021Q3 | us-gaap |
Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
|
527637000 | USD |
CY2021Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
226000 | USD |
CY2020Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
206000 | USD |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
644000 | USD | |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
643000 | USD | |
CY2021Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P78Y8M12D | |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P79Y6M | |
CY2021Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0574 | |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0574 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
213000 | USD |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
526000 | USD |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
530000 | USD |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
534000 | USD |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
538000 | USD |
CY2021Q3 | ahr |
Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
|
46565000 | USD |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
48906000 | USD |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
38885000 | USD |
CY2021Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
10021000 | USD |
us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
4 | segment | |
CY2021Q3 | us-gaap |
Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
|
22120000 | USD |
CY2020Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-39000 | USD |
CY2020Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-5152000 | USD |
us-gaap |
Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
|
66054000 | USD | |
CY2021Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
15090000 | USD |
CY2021Q3 | us-gaap |
Revenues
Revenues
|
37210000 | USD |
CY2021Q3 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
6389000 | USD |
CY2021Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
14540000 | USD |
CY2021Q3 | ahr |
Segmentnetoperatingincome
Segmentnetoperatingincome
|
16281000 | USD |
CY2021Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4304000 | USD |
CY2021Q3 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
3800000 | USD |
CY2021Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
10746000 | USD |
CY2021Q3 | us-gaap |
Interest Expense
InterestExpense
|
4961000 | USD |
CY2021Q3 | us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
1514000 | USD |
CY2021Q3 | us-gaap |
Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
|
15000 | USD |
CY2021Q3 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
70000 | USD |
CY2021Q3 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
33000 | USD |
CY2021Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-3329000 | USD |
CY2021Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-5898000 | USD |
CY2020Q3 | us-gaap |
Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
|
21519000 | USD |
CY2020Q3 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
5905000 | USD |
CY2020Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
18948000 | USD |
CY2020Q3 | ahr |
Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
|
864000 | USD |
CY2020Q3 | ahr |
Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
|
41331000 | USD |
CY2020Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
17397000 | USD |
CY2020Q3 | ahr |
Segmentnetoperatingincome
Segmentnetoperatingincome
|
18029000 | USD |
CY2020Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3672000 | USD |
CY2020Q3 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
57000 | USD |
CY2020Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
12669000 | USD |
CY2020Q3 | us-gaap |
Interest Expense
InterestExpense
|
4839000 | USD |
CY2020Q3 | us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
1450000 | USD |
CY2020Q3 | us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
3064000 | USD |
CY2020Q3 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-377000 | USD |
CY2020Q3 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
8000 | USD |
CY2020Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-6822000 | USD |
CY2020Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-5191000 | USD |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
46179000 | USD | |
us-gaap |
Revenues
Revenues
|
112233000 | USD | |
us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
18542000 | USD | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
44179000 | USD | |
ahr |
Segmentnetoperatingincome
Segmentnetoperatingincome
|
49512000 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11710000 | USD | |
us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
6552000 | USD | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
33745000 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
14556000 | USD | |
us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
4431000 | USD | |
us-gaap |
Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
|
-184000 | USD | |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-1027000 | USD | |
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
49000 | USD | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-11287000 | USD | |
us-gaap |
Profit Loss
ProfitLoss
|
-13782000 | USD | |
us-gaap |
Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
|
64824000 | USD | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
51863000 | USD | |
ahr |
Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
|
864000 | USD | |
ahr |
Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
|
117551000 | USD | |
us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
17723000 | USD | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
44856000 | USD | |
ahr |
Segmentnetoperatingincome
Segmentnetoperatingincome
|
54972000 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11960000 | USD | |
us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
74000 | USD | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
37919000 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
15123000 | USD | |
us-gaap |
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
|
-2302000 | USD | |
us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
3064000 | USD | |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
952000 | USD | |
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
278000 | USD | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-19259000 | USD | |
us-gaap |
Profit Loss
ProfitLoss
|
-14240000 | USD | |
us-gaap |
Profit Loss
ProfitLoss
|
-14240000 | USD | |
CY2021Q3 | us-gaap |
Assets
Assets
|
1063896000 | USD |
CY2020Q4 | us-gaap |
Assets
Assets
|
1092773000 | USD |
CY2021Q3 | ahr |
Concentration Risk Number Of States That Generated At Least Ten Percent Of Annualized Base Rent
ConcentrationRiskNumberOfStatesThatGeneratedAtLeastTenPercentOfAnnualizedBaseRent
|
2 | State |
CY2021Q3 | ahr |
Minimum Percent Share Of Each State Annualized Base Rent That Company Owned
MinimumPercentShareOfEachStateAnnualizedBaseRentThatCompanyOwned
|
0.100 | |
CY2021Q3 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
4 | segment |
CY2021Q3 | ahr |
Number Of Tenants With More Than Ten Percent Of Annual Base Rent
NumberOfTenantsWithMoreThanTenPercentOfAnnualBaseRent
|
1 | tenant |
CY2021Q3 | ahr |
Minimum Percent Share Of Annualized Base Rent Accounted By Tenants
MinimumPercentShareOfAnnualizedBaseRentAccountedByTenants
|
0.100 | |
CY2021Q3 | us-gaap |
Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
|
3000 | USD |
CY2020Q3 | us-gaap |
Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
|
4000 | USD |
us-gaap |
Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
|
12000 | USD | |
us-gaap |
Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
|
15000 | USD | |
CY2021Q3 | ahr |
Share Repurchase Plan Percentageof Priceper Share Condition Four
ShareRepurchasePlanPercentageofPriceperShareConditionFour
|
1 | |
CY2021Q3 | ahr |
Number Of Board Of Directors
NumberOfBoardOfDirectors
|
5 | facility |